Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01221532 · ClinicalTrials.gov registry record · NA
Support From Hospital to Home for Elders: A Randomized Controlled Study
A NA study of Hospital Readmissions, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 699
- Enrollment target
- 1
- Study location
NCT01221532 is a NA study of Hospital Readmissions that has completed, run by University of California, San Francisco. The registered enrollment target is 699 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01221532, a NA study of Hospital Readmissions, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 699 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will randomize 700 non-psychiatric, non-obstetric, non-surgical patients aged 55 years and older at San Francisco General Hospital (SFGH) to usual care (ten days of prescription medication, discharge summary sent to primary care provider (PCP), and outpatient appt made for patient, and patient's nurse reviews discharge plan,) or usual care plus a peridischarge intervention (a visit with specialized in-hospital discharge nurse, development of personalized discharge plan, two phone calls from a nurse practitioner(NP)/physician assistant (PA) after discharge and availability of additional calls back from NP/PA, upon patient request, to help answer questions and assist patient's transition to outpatient care, and communication with primary care/subspecialty providers). The usual care and usual care plus intervention groups will be assessed for differences in mortality and rates of rehospitalization and emergency department use 30, 90 and 180 days following discharge from the hospital. The discharge process from the hospital to home is frequently marked by poor quality and high risk of adverse events and readmissions. It has been hypothesized that better coordinated care, personalized patient education, and follow-up calls to identify potential sources of adverse events, such as medical complications and medication errors can reduce rehospitalization and emergency room visits following discharge from the hospital. Although these interventions have been shown to reduce combined hospital readmissions and emergency department visits in English-speaking patients, none has focused on elderly patients in a diverse urban public hospital setting that includes non-English-speakers, who might benefit more than other populations from enhanced services during and after discharge from the hospital. Further, these labor-intensive interventions are costly to implement, and it is unknown whether opportunity cost of providing additional services in a limited-resource e
Conditions Studied
Interventions
- BEHAVIORAL SHHE Peridischarge Intervention
Study Locations (1)
California
- San Francisco General Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 699 participants |
| Start Date | 2010-07 |
| Est. Completion | 2013-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01221532
The ClinicalTrials.gov registry entry for NCT01221532 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 699 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hospital Readmissions appearing as the primary indexed condition, and to 1 intervention - of which SHHE Peridischarge Intervention is the first listed.
NCT01221532 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01221532 about?
NCT01221532 is a clinical study titled "Support From Hospital to Home for Elders: A Randomized Controlled Study". The investigators will randomize 700 non-psychiatric, non-obstetric, non-surgical patients aged 55 years and older at San Francisco General Hospital (SFGH) to usual care (ten days of prescription medication, discharge summary sent to primary care provider (PCP), and outpatient appt made for patient,...
What is the current status of trial NCT01221532?
This trial is currently completed. It is a NA study. The enrollment target is 699 participants. The study started on 2010-07. Estimated completion is 2013-07.
What conditions does trial NCT01221532 study?
This clinical trial studies the following conditions: Hospital Readmissions.
What interventions are being tested in trial NCT01221532?
The interventions under investigation include: SHHE Peridischarge Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01221532?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01221532 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hospital Readmissions
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.